← FDA DRUG APPROVALS

FDA ANDA · ANDA086308

HOMAPIN-10

Sponsor: MISSION PHARMA

APPLICATION
ANDA086308
TYPE
ANDA
ORIGINAL APPROVAL
1979-04-11
LATEST ACTION
1992-07-06
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HOMAPIN-10Discontinued
HOMATROPINE METHYLBROMIDE 10MG · TABLET · ORAL

Approval history

1992-07-06Labeling · Supplement 4AP
1979-04-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →